相似文献
1
Commentary: Dysthyroid optic neuropathy: A lurking danger in thyroid eye disease.
Indian J Ophthalmol. 2022 Dec;70(12):4428-4429. doi: 10.4103/ijo.IJO_2126_22.
2
Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab.
Eur J Ophthalmol. 2022 May;32(3):NP46-NP49. doi: 10.1177/1120672121991042. Epub 2021 Feb 1.
3
Imaging of dysthyroid optic neuropathy.
Eur J Ophthalmol. 2024 Sep;34(5):1346-1354. doi: 10.1177/11206721231199367. Epub 2023 Sep 6.
4
Compressive Optic Neuropathy in Thyroid Eye Disease.
Int Ophthalmol Clin. 2016 Winter;56(1):51-67. doi: 10.1097/IIO.0000000000000096.
5
Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment.
Curr Opin Neurol. 2021 Feb 1;34(1):116-121. doi: 10.1097/WCO.0000000000000894.
6
Diagnosis and Management of Dysthyroid Optic Neuropathy.
Int Ophthalmol Clin. 2023 Jul 1;63(3):233-248. doi: 10.1097/IIO.0000000000000452. Epub 2023 Jun 22.
7
Teprotumumab for Optic Neuropathy in Thyroid Eye Disease.
JAMA Ophthalmol. 2021 Feb 1;139(2):244-247. doi: 10.1001/jamaophthalmol.2020.5296.
8
[Efficacy of transethmoidal orbital decompression in patients with dysthyroid optic neuropathy].
Vestn Otorinolaringol. 2020;85(6):52-55. doi: 10.17116/otorino20208506152.
9
[Ocular hypertension and optic neuropathies secondary to dysthyroid orbitopathy: Review of the literature].
J Fr Ophtalmol. 2021 Oct;44(8):1256-1261. doi: 10.1016/j.jfo.2021.01.026. Epub 2021 Jul 21.
10
Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
Folia Med (Plovdiv). 2020 Jun 30;62(2):418-423. doi: 10.3897/folmed.62.e47689.
本文引用的文献
1
Dysthyroid optic neuropathy: Demographics, risk factors, investigations, and management outcomes.
Indian J Ophthalmol. 2022 Dec;70(12):4419-4426. doi: 10.4103/ijo.IJO_719_22.
2
Diagnostic Ability of Barrett's Index and Presence of Intracranial Fat Prolapse in Dysthyroid Optic Neuropathy.
Clin Ophthalmol. 2022 Aug 12;16:2569-2578. doi: 10.2147/OPTH.S364987. eCollection 2022.
3
Peripapillary structural and microvascular alterations in early dysthyroid optic neuropathy.
Eye Vis (Lond). 2022 Aug 9;9(1):30. doi: 10.1186/s40662-022-00301-6.
4
Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery.
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3683-3691. doi: 10.1007/s00417-022-05732-4. Epub 2022 Jun 22.
5
Orbital MRI 3D Reconstruction Based on Volume Rendering in Evaluating Dysthyroid Optic Neuropathy.
Curr Eye Res. 2022 Aug;47(8):1179-1185. doi: 10.1080/02713683.2022.2066697. Epub 2022 May 23.
6
Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review.
Clin Ophthalmol. 2022 Mar 18;16:841-850. doi: 10.2147/OPTH.S284609. eCollection 2022.
Zotero 插件